|
Mental disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Evidence suggests that mice deficient in Tph2, the rate-limiting enzyme for brain serotonin synthesis, display disruptions in behavioral phenotypes relevant to stress-related psychiatric disorders.
|
31319134 |
2019 |
|
Mental disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
This dual role of TPH2 should be taken into consideration during therapy of psychiatric disorders.
|
31216212 |
2019 |
|
Mental disorders
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Characterizing how exactly the different TPH2 variants influence the serotonergic neurotransmission is a next necessary step in understanding the psychiatric disorders where serotonin is implicated.
|
29775696 |
2018 |
|
Mental disorders
|
0.100 |
GeneticVariation
|
group |
BEFREE |
We examined whether the TPH2 polymorphism -703G/T (rs4570625) is associated with aggressiveness and impulsivity, and the prevalence of psychiatric disorders, in a population-representative sample.
|
28342337 |
2017 |
|
Mental disorders
|
0.100 |
GeneticVariation
|
group |
BEFREE |
These findings suggest that the association of risk for psychiatric disorders with a common TPH2 yin haplotype is related to the inefficient functional engagement of cortical areas involved in cognitive control and alterations in the mode of functional connectivity of dACC pathways.
|
22915309 |
2012 |
|
Mental disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
The gene for tryptophan hydroxylase 2, which is a rate limiting enzyme in serotonin synthesis, is considered an important candidate gene associated with psychiatric disorders.
|
21829912 |
2011 |
|
Mental disorders
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Risk-taking behavior in a gambling task associated with variations in the tryptophan hydroxylase 2 gene: relevance to psychiatric disorders.
|
20043001 |
2010 |
|
Mental disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Tryptophan hydroxylase 2 (TPH2) which is a rate limiting enzyme in the serotonin synthesis is considered an important candidate gene associated with psychiatric disorders.
|
19800079 |
2010 |
|
Mental disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Although the predominant role of tryptophan hydroxylase 2 (TPH2) in the CNS and its influence on the vulnerability to psychiatric disorders have clearly been demonstrated in several studies, the role of TPH1 on neuronal mechanisms, respectively on behavioral traits is still poorly understood.
|
19233335 |
2009 |
|
Mental disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
The rate-limiting enzyme of serotonin biosynthesis, tryptophan hydroxylase 2 (TPH2), is one of the most promising candidate genes for psychiatric disorders.
|
19588223 |
2009 |
|
Mental disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
Sixteen TPH2 SNPs were genotyped in a Romanian sample of 198 BPI patients and 180 controls screened for psychiatric disorders.
|
18797398 |
2008 |
|
Mental disorders
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Despite reports of possible associations between polymorphisms in human TPH2 and many psychiatric disorders, including bipolar disorder (BPD), the functional effect and susceptibility loci of such polymorphisms for BPD have not yet been identified.
|
17768266 |
2007 |
|
Mental disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
The novel tryptophan hydroxylase isoform (TPH2), being the rate-limiting enzyme in the biosynthesis of serotonin, has many biological functions and plays an important role as candidate gene in several psychiatric disorders.
|
17011525 |
2006 |
|
Mental disorders
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tryptophan hydroxylase 2 (TPH2) was found to be solely expressed in the brain and therefore considered an important susceptibility gene in psychiatric disorders.
|
17015812 |
2006 |